There are over 15 million people living with spinal cord injury (SCI) worldwide. Experimental treatments using electrical ...

Two state-first clinical trials are aiming to bring life-changing movement back to people who live with paralysis through ...

A new study reveals the key lies not in the production of a regrowth molecule, but in that molecule's controlled destruction.

The research builds on more than a decade of neuroscience and bioengineering work at UT Dallas. Previous studies showed that ...

The 38-year-old Rio 2016 bronze medallist had retired from competitive swimming in 2019. Read more at straitstimes.com. Read ...

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neuroreparative ...

DataM Intelligence | competitive Intelligence Spinal Muscular Atrophy treatment is evolving fast, with gene therapy, oral drugs, and next-g ...

Researchers have found a new and distinct pathway for chronic pain and have mapped how to target it with therapies, offering hope for people with fibromyalgia and chronic pain.

Detailed price information for Nurexone Biologic Inc (NRX-X) from The Globe and Mail including charting and trades.

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...